Imprimis acquires compounding pharmacy
Imprimis Pharmaceuticals has acquired Pharmacy Creations, a compounding pharmacy, according to a press release.
The acquisition will allow Imprimis, which develops and commercializes proprietary and novel sterile and topical drug formulations, to make and distribute patent-pending proprietary drug formulations and other novel pharmaceutical solutions, the release said.
Imprimis and Pharmacy Creations have been working together since last year when Imprimis acquired the intellectual property for its suite of ophthalmic formulations from Pharmacy Creations' co-founders, the release said.
The acquisition is expected to be completed by March 31.